Clinical trial
Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive…
NCT00285012 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00285012 |
|---|---|
| Title | Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD). |
| Official title | A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial With 40-Week Follow-Up Evaluating The Safety And Efficacy Of Varenicline Tartrate For Smoking Cessation In Patients With Mild-To-Moderate Chronic Obstructive Pulmonary Disease |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Smoking Cessation |
| Intervention type | Drug |
| Interventions | placebo, Varenicline Tartarate |
| Enrollment | 504 |
| Start date | May 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Apr 1, 2009 |
| First posted | Feb 1, 2006 |
| Last update posted | Apr 20, 2010 |
| Countries | France, Italy, Spain, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: